| Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research AIR Maas, DK Menon, PD Adelson, N Andelic, MJ Bell, A Belli, P Bragge, ... The Lancet Neurology 16 (12), 987-1048, 2017 | 2441 | 2017 |
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ... Nature genetics 43 (5), 436-441, 2011 | 2252 | 2011 |
| Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans Nature communications 7 (1), 11934, 2016 | 1114 | 2016 |
| Traumatic brain injury: progress and challenges in prevention, clinical care, and research AIR Maas, DK Menon, GT Manley, M Abrams, C Åkerlund, N Andelic, ... The Lancet Neurology 21 (11), 1004-1060, 2022 | 676 | 2022 |
| High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial PS Aisen, LS Schneider, M Sano, R Diaz-Arrastia, CH Van Dyck, ... Jama 300 (15), 1774-1783, 2008 | 671 | 2008 |
| Diagnosis, prognosis, and clinical management of mild traumatic brain injury HS Levin, RR Diaz-Arrastia The Lancet Neurology 14 (5), 506-517, 2015 | 638 | 2015 |
| The chronic and evolving neurological consequences of traumatic brain injury L Wilson, W Stewart, K Dams-O'Connor, R Diaz-Arrastia, L Horton, ... The Lancet Neurology 16 (10), 813-825, 2017 | 565 | 2017 |
| Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes G Jun, AC Naj, GW Beecham, LS Wang, J Buros, PJ Gallins, JD Buxbaum, ... Archives of neurology 67 (12), 1473-1484, 2010 | 519 | 2010 |
| A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC) GWJ Hawryluk, S Aguilera, A Buki, E Bulger, G Citerio, DJ Cooper, ... Intensive care medicine 45, 1783-1794, 2019 | 495 | 2019 |
| Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein R Diaz-Arrastia, KKW Wang, L Papa, MD Sorani, JK Yue, AM Puccio, ... Journal of neurotrauma 31 (1), 19-25, 2014 | 487 | 2014 |
| β-Amyloid burden in healthy aging: regional distribution and cognitive consequences KM Rodrigue, KM Kennedy, MD Devous Sr, JR Rieck, AC Hebrank, ... Neurology 78 (6), 387-395, 2012 | 476 | 2012 |
| Brain oxygen optimization in severe traumatic brain injury phase-II: a phase II randomized trial DO Okonkwo, LA Shutter, C Moore, NR Temkin, AM Puccio, CJ Madden, ... Critical care medicine 45 (11), 1907-1914, 2017 | 471 | 2017 |
| In vivo staging of regional amyloid deposition MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ... Neurology 89 (20), 2031-2038, 2017 | 438 | 2017 |
| A multidimensional approach to post-concussion symptoms in mild traumatic brain injury S Polinder, MC Cnossen, RGL Real, A Covic, A Gorbunova, ... Frontiers in neurology 9, 1113, 2018 | 434 | 2018 |
| Dementia resulting from traumatic brain injury: what is the pathology? S Shively, AI Scher, DP Perl, R Diaz-Arrastia Archives of neurology 69 (10), 1245-1251, 2012 | 421 | 2012 |
| Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy ME Gurol, MC Irizarry, EE Smith, S Raju, R Diaz-Arrastia, T Bottiglieri, ... Neurology 66 (1), 23-29, 2006 | 411 | 2006 |
| Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families C Cruchaga, S Chakraverty, K Mayo, FLM Vallania, RD Mitra, K Faber, ... PloS one 7 (2), e31039, 2012 | 402 | 2012 |
| Recovery after mild traumatic brain injury in patients presenting to US level I trauma centers: a transforming research and clinical knowledge in traumatic brain injury (TRACK … LD Nelson, NR Temkin, S Dikmen, J Barber, JT Giacino, E Yuh, HS Levin, ... JAMA neurology 76 (9), 1049-1059, 2019 | 390 | 2019 |
| Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ... Neurology 85 (14), 1240-1249, 2015 | 368 | 2015 |
| Homocysteine and neurologic disease R Diaz-Arrastia Archives of neurology 57 (10), 1422-1427, 2000 | 355 | 2000 |
Kimbra KenneyEmail verificata su usuhs.edu
